Cambridge Investment Research Advisors, Inc. - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 151 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$98,000
-7.5%
21,880
-5.4%
0.00%
-50.0%
Q2 2017$106,000
+12.8%
23,130
+3.6%
0.00%0.0%
Q1 2017$94,000
+3.3%
22,330
+0.9%
0.00%0.0%
Q4 2016$91,000
-63.2%
22,130
-27.3%
0.00%
-60.0%
Q3 2016$247,000
-2.8%
30,435
-6.4%
0.01%0.0%
Q2 2016$254,000
+0.8%
32,510
-0.4%
0.01%
-16.7%
Q1 2016$252,000
-44.1%
32,635
-21.9%
0.01%
-45.5%
Q4 2015$451,000
+198.7%
41,780
+91.6%
0.01%
+175.0%
Q3 2015$151,000
+34.8%
21,805
+72.3%
0.00%
+33.3%
Q2 2015$112,000
-9.7%
12,655
+0.8%
0.00%
-25.0%
Q1 2015$124,00012,5550.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
RA Capital Management 11,733,815$81,081,00011.64%
RTW INVESTMENTS, LP 2,589,818$17,896,0005.56%
DAFNA Capital Management LLC 480,300$3,319,0003.29%
DOHENY ASSET MANAGEMENT /CA 510,125$3,525,0001.83%
Sio Capital Management, LLC 364,368$2,518,0001.73%
TURNER INVESTMENTS LLC 1,086,000$7,504,0001.52%
Ghost Tree Capital, LLC 300,000$2,073,0000.93%
Rock Springs Capital Management LP 1,125,000$7,774,0000.63%
SENZAR ASSET MANAGEMENT, LLC 619,000$4,277,290,0000.62%
Point72 Asset Management, L.P. 9,772,018$67,525,0000.53%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders